AMBEV S.A. current report, Q2 FY2021

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. reports on a Board of Directors meeting held on June 9, 2021. The document serves as an extract of the minutes detailing corporate governance actions, specifically regarding capital increases resulting from employee stock option exercises. The reporting period for the specific transactions covered is between May 12, 2021, and June 1, 2021.

Key Financial Metrics

The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data presented relates to the capitalization of the company through stock option exercises.

  • Total New Shares Issued: 284,552 common shares.
  • Total Proceeds from Issuance: R$ 3,581,054.80.
  • Capital Stock Before: R$ 57,973,874,024.26.
  • Capital Stock After: R$ 57,977,455,079.06.
  • Total Registered Common Shares After: 15,739,527,854.

Material Changes

The material change reported is an increase in the company's authorized capital stock and the number of outstanding shares due to the exercise of stock options under the 2011.2 and 2014.2 Stock Option Programs. The capital stock increased by approximately R$ 3.58 million, and the total share count increased by 284,552 shares. No other material changes to operations or financial position are disclosed in this document.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a record of the Board's resolution to approve the capital increases and the subsequent issuance of shares to beneficiaries of the stock option programs. The new shares participate equally with existing shares in all benefits and advantages declared as of the date of issuance.

Investor Verification Points

  • Verify the impact of the 284,552 new shares on earnings per share (EPS) dilution in the next quarterly report.
  • Confirm the registration of the capital increase with the Board of Trade as mandated by the Board resolution.
  • Review the specific terms of the 2011.2 and 2014.2 Stock Option Programs to understand the vesting and exercise conditions.
  • Note that this filing does not contain operational performance data; refer to the most recent Form 20-F or quarterly earnings release for revenue and profit metrics.